ABCL Smart Money
AbCellera Biologics Inc.
1W: +9.6%
1M: -7.8%
3M: +138.0%
YTD: +274.1%
1Y: +126.7%
3Y: +197.0%
5Y: -19.7%
$12.83
+0.75 (+6.21%)
Weekly Expected Move ±10.2%
$9
$11
$12
$13
$14
Credit Risk of going bust: higher than 54% of companies Debt: 3.2% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.07 (down 99.5%), AbCellera Biologics Inc. would be worth roughly what it owes.
Total debt $135.6M against a stock market value of $4.16B.
Distance to default 4.70 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $67.8M (short-term plus half of long-term), stock volatility 83.0%; Altman Z'' 4.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $135.6M against a stock market value of $4.16B.
Distance to default 4.70 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $67.8M (short-term plus half of long-term), stock volatility 83.0%; Altman Z'' 4.07. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026178
Institutions Holding
+16 vs prior
21.5%
Ownership
+11.09%
40
New
36
Increased
80
Reduced
26
Closed
👔 Insider Trades
14 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-24 | Hayden Michael R | director | P-Purchase | 53,613 | $10.64 | $570K | Filing |
| 2026-08-18 | Montalbano John S. | director | P-Purchase | 10,000 | $11.03 | $110K | Filing |
| 2026-08-14 | Booth Andrew | officer: chief financial officer | P-Purchase | 37,200 | $10.32 | $384K | Filing |
| 2026-08-12 | Hayden Michael R | director | P-Purchase | 46,387 | $10.37 | $481K | Filing |
| 2026-08-11 | Hayden Michael R | director | G-Gift | 50,000 | $— | $0 | Filing |
| 2026-05-14 | Montalbano John S. | director | P-Purchase | 20,000 | $4.77 | $95K | Filing |
| 2026-02-27 | Booth Andrew | officer: chief financial officer | P-Purchase | 42,600 | $3.42 | $146K | Filing |
| 2026-02-27 | Thermopylae Holdings Ltd. | 10% owner | P-Purchase | 38,000 | $3.44 | $131K | Filing |
| 2026-02-26 | Thermopylae Holdings Ltd. | 10% owner | P-Purchase | 177,457 | $3.27 | $580K | Filing |
| 2025-12-18 | Thermopylae Holdings Ltd. | 10% owner | G-Gift | 225,000 | $— | $0 | Filing |
| 2025-11-26 | Montalbano John S. | director | P-Purchase | 50,000 | $3.57 | $178K | Filing |
| 2025-03-11 | Thermopylae Holdings Ltd. | 10% owner | P-Purchase | 343,631 | $2.16 | $742K | Filing |
| 2025-03-10 | Montalbano John S. | director | P-Purchase | 25,000 | $2.30 | $57K | Filing |
| 2025-03-06 | Montalbano John S. | director | P-Purchase | 60,000 | $2.34 | $141K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | 33,012,138 | $259M | +2,736,200 | 2026-06-30 | Filing |
| Capital World Investors | 13,588,349 | $107M | +227,253 | 2026-06-30 | Filing |
| TWO SIGMA INVESTMENTS, LP | 10,437,431 | $82M | -124,634 | 2026-06-30 | Filing |
| TD Waterhouse Canada Inc. | 9,568,149 | $73M | +3,490 | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 6,141,539 | $48M | +3,141,603 | 2026-06-30 | Filing |
| UBS AM, a distinct business unit of UBS | 4,317,206 | $34M | -3,258,270 | 2026-06-30 | Filing |
| ArrowMark Colorado Holdings LLC | 4,105,095 | $32M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 3,805,309 | $30M | -234,927 | 2026-06-30 | Filing |
| Driehaus Capital Management LLC | 2,864,729 | $22M | -1,160,050 | 2026-06-30 | Filing |
| TUDOR INVESTMENT CORP ET AL | 2,063,191 | $16M | -210,298 | 2026-06-30 | Filing |
| MARSHALL WACE, LLP | 1,902,191 | $15M | +1,542,508 | 2026-06-30 | Filing |
| UBS Group AG | 1,870,633 | $15M | -2,338,419 | 2026-06-30 | Filing |
| MORGAN STANLEY | 1,669,014 | $13M | -555,815 | 2026-06-30 | Filing |
| CITADEL ADVISORS LLC | 1,586,512 | $12M | +225,407 | 2026-06-30 | Filing |
| NATIONAL BANK OF CANADA /FI | 1,233,014 | $10M | +1,231,621 | 2026-06-30 | Filing |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1,039,927 | $8M | +1,039,927 | 2026-06-30 | Filing |
| RENAISSANCE TECHNOLOGIES LLC | 990,929 | $8M | -519,700 | 2026-06-30 | Filing |
| Counterpoint Mutual Funds LLC | 971,643 | $8M | +971,643 | 2026-06-30 | Filing |
| STATE STREET CORP | 731,362 | $6M | +1,149 | 2026-06-30 | Filing |
| HRT FINANCIAL LP | 705,506 | $6M | -529,647 | 2026-06-30 | Filing |